The Control Yuan yesterday charged former Democratic Progressive Party (DPP) chairperson Tsai Ing-wen (蔡英文) with dereliction of her duties when she facilitated government investments in Yu Chang Biologics Co (宇昌生技) in 2007.
Control Yuan members Ma Yi-kung (馬以工), Yeh Yao-peng (葉耀鵬), Ma Hsiu-ju (馬秀如) and Lee Ful-dien (李復甸) called a press conference yesterday to publicize their investigation report on the Yu Chang case.
The case emerged in the run-up to the presidential election in January last year, when the Chinese Nationalist Party (KMT) accused Tsai, then the DPP presidential candidate, of playing an improper role in the formation of Yu Chang Biologics Co, now known as TaiMed Biologics Inc (中裕新藥).
Photo: Wang Min-wei, Taipei Times
In August last year, the Supreme Prosecutors’ Office Special Investigation Division closed its investigation into the case, finding no evidence of wrongdoing against Tsai.
Tsai was then accused of corruption because she approved separate government investments of NT$875 million (US$29.6 million) and US$20 million — about NT$1.4 billion in total — for the biotechnology start-up before leaving office as vice premier, and later served as Yu Chang chairperson.
Ma Yi-kung dismissed speculation about the timing of the report’s release — at a time when President Ma Ying-jeou’s (馬英九) administration and the KMT are embroiled in what has been termed the “September political strife” — saying that the meeting to review the report had been scheduled for Sept. 4, before the case at the center of the political strife came to light on Sept. 6.
In the report, the Control Yuan members concluded that it was “obvious” that Tsai’s actions “constituted dereliction of [her] duties” in approving government funds to be invested in Yu Chang Biologics.
The appropriation procedure through which the then-DPP government decided to authorize the investment was processed by a handful of people in the government, which was an unusual practice, the report said.
Tsai approved the investments without seeking then-premier Su Tseng-chang’s (蘇貞昌) views when the US biotech giant Genentech, then a potential partner of Yu Chang Biologics Co, proposed a less favorable cooperation plan with the new company compared with its previous proposal, which Su had agreed to, the report said.
When asked to specify irregularities involving Tsai that they discovered in the investigation, Ma Yi-kung said the Control Yuan would send its investigation report to the Ministry of Justice.
The four Control Yuan members proposed that the Executive Yuan and the Council for Economic Planning and Development, in charge of the government funds, be censored over the case and the motion was adopted.
The investigation by the four Control Yuan members began in February last year.
The Yu Chang case was also probed by the Anti-Corruption Committee of the Control Yuan. The committee closed the case in February, finding no evidence that Tsai committed any irregularities under the Public Officials’ Conflicts of Interest Prevention Act (公職人員利益衝突迴避法).
Tsai’s office yesterday said the Control Yuan’s report was flawed and appeared to be a tactic by the Ma administration to shift the focus away from its own ongoing political turmoil.
At a press conference, DPP Legislator Chen Chi-mai (陳其邁) announced a four-point statement on behalf of Tsai, who did not attend the press conference, saying that the Yu Chang case was a discreditation campaign Ma had orchestrated for personal political gain during the presidential campaign in 2011, and which ended up hurting Taiwan’s biotech industry.
“We suspect the Control Yuan has become a political tool of the Ma administration, which has infringed on the constitutional mechanism and launched a political purge, and tried to portray Tsai and other DPP members as corrupt politicians,” Chen said.
The conclusion of the report had several fatal mistakes, lawyer Wellington Koo (顧立雄) said.
The report accused Tsai of having unilaterally approved the National Development Fund investment in Yu Chang Biologics without informing Su.
However, the document Tsai had approved was only a progress report on the negotiation of the investment plan, and the final approval of the plan was approved by former premier Chang Chun-hsiung (張俊雄) after Tsai and Su left the Cabinet in September 2007, Koo said.
“This case has been spreading rumors from the first minute and the Control Yuan’s report was ridiculous,” Koo said, adding that the report seemed to be a vicious attempt to sow dissension between Tsai and Su, who many believe will be fighting for the DPP’s nomination for the next presidential election.
Taiwan might be China’s next target after it has “walled off” Hong Kong from the rest of the world with its new national security legislation, Academia Sinica Institute of Sociology fellow Wu Jieh-min (吳介民) said on Thursday. At a seminar organized by the Economic Democracy Union, the Taiwan Association for Human Rights, the Hong Kong Outlanders and the Judicial Reform Foundation, Wu said that the legislation is simultaneously a fig leaf concealing Beijing’s autocratic rule in Hong Kong and a figurative “Berlin Wall,” denying democratic countries access to Hong Kong. Wu said it is evident that Taiwan would be China’s next target. The
YOUNGEST PATIENT: Cases of botulism have been only sporadically reported over the past few years, with two in 2015, six in 2016 and none in the past three years The Centers for Disease Control (CDC) yesterday reported the nation’s first case of infant botulism this year, a four-month-old boy in northern Taiwan, as well as five new cases of Japanese encephalitis confirmed last week. The boy was introduced to homemade solid food in the middle of last month, but began to experience constipation and loss of appetite on June 23, CDC Epidemic Intelligence Center Deputy Director Guo Hung-wei (郭宏偉) said, adding that he was taken to the hospital when he developed a fever and shortness of breath on June 25. In the hospital, the boy also experienced a rapid heartbeat, limb
The National Taiwan Museum’s Railway Department Park in Taipei is to open to the public today. The park in Datong District (大同) near the North Gate (北門, Beimen) is one of the museum’s four branches. During the Japanese colonial era, the site housed the railway department of the Office of the Governor-General of Taiwan’s Bureau of Transportation. After World War II, it served as the headquarters for the Taiwan Railways Administration (TRA) for several decades. In 2007, it was listed as a national monument under the Cultural Heritage Preservation Act (文化資產保存法). At an opening ceremony yesterday, Minister of Transportation and Communications Lin Chia-lung
CHALLENGER DEEP: Lin Ying-Tsong was invited by Caladan Oceanic founder Victor Vescovo to join him on a 10-hour long trip in the company’s submersible Taiwanese-American Lin Ying-Tsong (林穎聰) last month became the first person from Asia and the 12th in human history to dive into the deepest part on Earth, the Challenger Deep in the Mariana Trench. Lin, 45, an expert in deep sea acoustics with the Woods Hole Oceanographic Institution (WHOI) in Massachusetts, joined US adventurer and Caladan Oceanic founder Victor Vescovo, 54, on June 22 in a descent to the central pool of the Challenger Deep, the deepest point of the trench, which lies at a depth of more than 10,900m. The pair made the descent in a submersible named Limiting Factor, a US$37
RSS